Syrosingopine
Overview[edit]
Syrosingopine is a pharmaceutical compound known for its role as an antihypertensive agent. It is a derivative of reserpine, a well-known alkaloid used in the treatment of high blood pressure. Syrosingopine functions by depleting catecholamines and serotonin from peripheral sympathetic nerve endings, leading to a decrease in blood pressure.
Mechanism of Action[edit]
Syrosingopine works primarily by inhibiting the vesicular monoamine transporter 2 (VMAT2), which is responsible for the uptake of neurotransmitters such as norepinephrine, dopamine, and serotonin into synaptic vesicles. By blocking this transporter, syrosingopine reduces the storage of these neurotransmitters in vesicles, leading to their depletion in the synaptic cleft and a subsequent decrease in sympathetic nervous system activity.
Clinical Uses[edit]
Syrosingopine has been used in the management of hypertension, particularly in cases where other treatments have proven ineffective. Its use, however, has declined with the development of newer antihypertensive agents that have more favorable side effect profiles.
Side Effects[edit]
The side effects of syrosingopine are similar to those of reserpine and include depression, nasal congestion, gastrointestinal disturbances, and bradycardia. Due to its ability to deplete neurotransmitters, it can also lead to symptoms of depression and sedation.
Pharmacokinetics[edit]
Syrosingopine is administered orally and is absorbed through the gastrointestinal tract. It is metabolized in the liver and excreted primarily through the kidneys. The drug has a relatively long half-life, which allows for once-daily dosing.
Related Compounds[edit]
Syrosingopine is chemically related to other rauwolfia alkaloids, such as reserpine. These compounds share a similar mechanism of action and are used in the treatment of hypertension and certain psychiatric disorders.
Research and Development[edit]
Recent studies have explored the potential of syrosingopine in combination with other drugs for the treatment of cancer. Its ability to inhibit VMAT2 has been investigated for its potential to enhance the efficacy of certain chemotherapeutic agents.
Related Pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
